CAS 7081-38-1

Oxyphenbutazone monohydrate

Description:

Oxyphenbutazone monohydrate is a non-steroidal anti-inflammatory drug (NSAID) primarily used for its analgesic and anti-inflammatory properties. It is a derivative of phenylbutazone and is characterized by its ability to inhibit cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins, which are mediators of inflammation and pain. The monohydrate form indicates that the compound contains one molecule of water per molecule of oxyphenbutazone, which can influence its solubility and stability. Typically, oxyphenbutazone is administered in tablet form and is indicated for conditions such as arthritis and gout. Its pharmacokinetics involve absorption in the gastrointestinal tract, with a relatively long half-life, allowing for sustained therapeutic effects. However, it is important to note that oxyphenbutazone can have side effects, including gastrointestinal issues and potential hematological effects, necessitating careful monitoring during use. As with any medication, it is essential to use oxyphenbutazone under medical supervision to mitigate risks and ensure appropriate therapeutic outcomes.

Formula: C₁₉H₂₂N₂O₄

InChI: InChI=1/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2

InChI key: InChIKey=CNDQSXOVEQXJOE-UHFFFAOYSA-N

SMILES: O=C1N(N(C(=O)C1CCCC)C2=CC=CC=C2)C3=CC=C(O)C=C3.O

Synonyms:

• 1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione monohydrate
• 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-, hydrate (1:1)
• 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-, monohydrate
• 3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-, monohydrate
• 4-Butyl-1-(4-Hydroxyphenyl)-2-Phenylpyrazolidine-3,5-Dione Hydrate (1:1)
• 4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione monohydrate
• Oxyphenbutazone [USAN:INN:BAN]
• Oxyphenbutazone monohydrate
• Tandearil monohydrate
• Unii-H806S4B3Ns
• Oxyphenbutazone DISCONTINUED (1 g)
• OXYPHENBUTAZONE HYDRATE USP/EP/BP
• OXYPHENBUTAZONE HYDRATE
• 1-(4-hydroxyphenyl)-4-(3-oxobutyl)-2-phenylpyrazolidin-3-one:hydrate

Oxyphenbutazone Monohydrate

CAS: 7081-38-1

Color and Shape: Neat

Ref: 61-FOR0933.00

Oxyphenbutazone Monohydrate

Controlled Product

CAS: 7081-38-1

Formula: C₁₉H₂₀N₂O₃·H₂O

Color and Shape: Neat

Molecular weight: 342.39

Ref: 86-MM0933.00

Oxyphenbutazone (hydrate) - Bio-X ™

CAS: 7081-38-1

This product is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

Formula: C₁₉H₂₀N₂O₃•H₂O

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 342.39 g/mol

Ref: 3D-BO300108

Oxyphenbutazone hydrate

CAS: 7081-38-1

Inhibitor of COX-1 and COX-2 cyclooxygenases

Formula: C₁₉H₂₀N₂O₃•H₂O

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 342.39 g/mol

Ref: 3D-FO35392

Oxyphenbutazone monohydrate

CAS: 7081-38-1

Oxyphenbutazone monohydrate: Phenylbutazone derivative, anti-inflammatory, non-selective COX inhibitor, kills dormant M. tuberculosis.

Formula: C₁₉H₂₂N₂O₄

Color and Shape: Solid

Molecular weight: 342.39

Ref: TM-T72177